On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The new online Learning Center with new content can still be found under the “Training” folder on ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...